The Supreme Court on Tuesday appeared skeptical of rolling back access to the abortion pill as they weighed arguments over whether pro-life doctors can challenge the Food and Drug Administration’s recent moves to increase access to the drug.
During nearly two hours of oral arguments, some justices suggested that the pro-life doctors lacked standing, or sufficient legal injury, to challenge the FDA’s changes to its distribution and usage of mifepristone, which is used with the drug misoprostol to terminate a pregnancy.
A lower court sided with the doctors and issued an injunction restricting the use of the pill. The Supreme Court put the injunction on hold while it granted the federal government’s appeal.
